Search

You searched for "pain"

1218 results found

EU: is it time to leave and embrace the world?

1 June 2016 | | EYE - General
Should the United Kingdom remain a member of the European Union (EU) or leave? It’s a big decision involving some complex issues, and there’s no doubt the EU will continue to change. Ipsos MORI’s monthly EU voting intention poll published...
Endoscopic Surgery of the Orbit book cover image.

Endoscopic Surgery of the Orbit: Anatomy, Pathology, and Management

3 June 2021 |
Endoscopic surgery still remains a challenge for many oculoplastic surgeons, whose main scope of work has traditionally been open surgery. The learning curve for endoscopic surgery is quite steep and this approach requires skills that needs to be well trained,...

Bleb-related changes in upper lid position

1 June 2016 | | EYE - Oculoplastic, EYE - Orbit
This is a review of five patients with upper lid ptosis or lid retraction secondary to large filtering blebs post-trabeculectomy. The authors review each case and apply a model to analyse the separate forces acting on the upper lid to...

Love will tear us apart again

4 February 2025 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Sophie: Bye. Love you! Mark: I love you, too. (It’s okay, everyone says it. I say I love Häagen-Dazs and my broadband provider, and I like Sophie more than them. In most respects.) Yes, Valentine’s Day is fast approaching again...

Well-presented scholarly research work will reduce chances of journal rebuttal

1 April 2018 | | EYE - General
Submitting to an academic journal? Are you aware of the requirements and constraints of relevant copyright laws? Rod McNeil provides a guide for aspiring authors. Getting published in peer-reviewed academic and medical journals is not easy. But careful attention to...

My top five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - Vitreo-Retinal
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

My Top Five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - General
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

The next wave of AI in ophthalmology: From screening to communication

19 February 2026 | | EYE - General
Artificial intelligence (AI) is reshaping ophthalmology, moving from research laboratories into everyday clinical care [1]. With its strong reliance on imaging and pattern recognition, ophthalmology is uniquely positioned to benefit from AI innovations. These developments range from autonomous disease screening...

Money is a problem, but the problem is bigger than money

3 February 2026 | | EYE - General
The argument surrounding doctors’ pay remains an ongoing battle. At the time of writing, Foundation Year 1 doctors have voted in favour of industrial action due to the lack of substantive employment or regular locum work at the end of...

The gift of family

3 February 2023 |
“Your kids look just like you!” is an oft-heard phrase at family gatherings. Setting aside the obvious explanation of basic genetics, similarities and recurrent character traits are well recognised within a family unit. Shared positive mutual experiences shape these attitudes...

Orbis marks 100-millionth antibiotic dose in the fight against trachoma in Ethiopia

12 May 2023 | Orbis, antibiotics, trachoma, Ethiopia
Orbis and partners mark historic 100-millionth dose of azithromycin antibiotics in the fight to eliminate blinding trachoma in Ethiopia by 2030. This milestone was achieved 20 years after Orbis began leading mass drug administrations.

Effective treatment for rare sight-threatening infection

1 November 2023 | Moorfields, UCL, SIFI S.p.A., Acanthamoeba, keratitis, corneal infection
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.